Skip to main content

US ClosedU.S. Closed

CTMX: CytomX Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

CytomX Therapeutics, Inc. is a United States-based biopharmaceutical company primarily focused on creating treatments for cancer.

52W Range

21stpctl

Volume

0.59×avg

Market Cap

698.83MUSD

P/E Ratio

-7.1TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

CytomX Therapeutics, Inc.

CTMXNASDAQ Global Select·USD·Closed

CytomX Therapeutics, Inc.

CTMXNASDAQ·USD·Closed

$3.21

−6.14%

$3.21

−$0.21 (6.14%)

52W Range

21stpctl

Volume

0.59×avg

Mkt Cap

698.83MUSD

P/E

-7.1TTM

Div Yield

–ann